|
n
|
15
|
15
|
16
|
-
|
|
Age (years)
|
50.3±9.0
|
59.7±17.2
|
61.9±17.0
|
0.66
|
|
Sex (% female)
|
100%
|
100%
|
100%
|
NA
|
|
Duration from onset (years)
|
-
|
5.7±10.2a
|
14.8±10.9a
|
0.064
|
|
Duration from diagnosis (years)
|
-
|
5.7±7.0
|
9.8±7.2b
|
0.079
|
|
BMI
|
-
|
25.6±4.6b
|
25.3±6.2b
|
0.88
|
|
Stimulated salivary flow rate
|
-
|
7.2±3.1 ml/5 min
|
1.5±0.9 ml/5 min
|
6.66 × 10-9
|
|
Schirmer right (mm/5 min)
|
-
|
8.0±9.3
|
5.5±5.9b
|
0.69
|
|
Schirmer left (mm/5 min)
|
-
|
7.9±7.4
|
6.5±7.0b
|
0.61
|
|
Anti-SSA
|
-
|
11/73.3%
|
13/86.7%c
|
0.39
|
|
Anti-SSB
|
-
|
2/13.3%
|
5/33.3%c
|
0.21
|
|
Seropositive (SSA and/or SSB)
|
-
|
11/73.3%
|
13/86.7%c
|
0.39
|
|
cMARD
|
-
|
5/35.7%d
|
4/33.3%e
|
0.93
|
|
bMARD (anti-TNF)
|
-
|
0/0.0%f
|
0/0.0%a
|
NA
|
|
Glucocorticoid
|
-
|
3/21.4%d
|
1/9.1%g
|
0.44
|
|
Cyclosporine eye drops
|
-
|
3/37.5%h
|
3/33.3%f
|
0.91
|
|
Oral pilocarpine
|
-
|
1/14.3%i
|
1/12.5%h
|
1
|
|
Natural tears
|
-
|
4/40.0%j
|
2/28.6%i
|
0.68
|
|
Angina pectoris
|
-
|
1b
|
0e
|
0.38
|
|
Autoimmune thyroid disease
|
-
|
0
|
2
|
0.18
|
|
Gynaecologic manifestation
|
-
|
1b
|
0e
|
0.38
|
|
Anemia
|
-
|
2b
|
0e
|
0.18
|
|
Leukopenia
|
-
|
1b
|
1e
|
1
|
|
Neutropenia
|
-
|
1b
|
0e
|
0.38
|
|
Cancer
|
-
|
1b
|
1e
|
1
|
